Enliven Therapeutics, Inc. - COMMON STOCK (ELVN)

CUSIP: 29337E102

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 6 signals
Share change
+5,455,752
SEC-reported price per share
$17.59
Number of holders
72
Value change
+$95,045,035
Number of buys
40
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
71,423,603

Security key

29337E102

Report period

Q1 2024

Institutions

72

Top holders

10

Ownership snapshot

Top reported holders of ELVN - Enliven Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
David P. Bonita
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
14 Feb 2024
3/4/5 13F Highest disclosed value: $124,536,998 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $124.54M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
David P. Bonita $63.55M
5AM Partners VI, LLC $57.16M
Commodore Capital LP $40.16M
New Enterprise Associates 14, L.P. $39.52M
RA CAPITAL MANAGEMENT, L.P. $32.12M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
David P. Bonita
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$63,552,894
4,207,568 shares
mixed-class rows
— 02 Jun 2022
5AM Partners VI, LLC
3/4/5
10%+ Owner
—
denominator unverified
$57,156,028
3,835,975 shares
— 14 Feb 2024
Commodore Capital LP
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$40,161,133
2,901,816 shares
— 31 Dec 2023
New Enterprise Associates 14, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$39,518,242
2,611,050 shares
— 05 Apr 2022
RA CAPITAL MANAGEMENT, L.P.
3/4/5 13F
Former 10% owner · Company
—
denominator unverified
$32,123,508
2,122,465 shares
— 23 Feb 2023
Braden M. Leonard
3/4/5
10%+ Owner
—
denominator unverified
$30,236,309
1,997,774 shares
— 03 Jan 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
72
Shares
44,456,336
Rows available
72
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
72
Q1 2024 holders
72
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .